ipodate has been researched along with Hyperthyroid in 15 studies
Ipodate: Ionic monomeric contrast media. Usually the sodium or calcium salts are used for examination of the gall bladder and biliary tract. (From Martindale, The Extra Pharmacopoeia, 30th ed, p704)
Excerpt | Relevance | Reference |
---|---|---|
"Consecutive patients with hyperthyroidism caused by Graves' disease or by multinodular toxic goiter were randomized to be treated with high-dose propylthiouracil (PTU) to block D1, PTU plus KI, or PTU plus sodium ipodate to additionally block D2." | 9.12 | Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. ( Christensen, SE; Helleberg, K; Laurberg, P; Nielsen, S; Pedersen, KM; Seefeldt, T; Vestergaard, H, 2007) |
"Five hyperthyroid patients (two men and three women) with typical features of subacute thyroiditis were treated with sodium ipodate (Oragrafin; 0." | 9.08 | Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. ( Chopra, IJ; Korenman, SG; van Herle, AJ; Viosca, S; Younai, S, 1995) |
"05) decrease in brain uptake of both labeled T3 (T3) and labeled thyroxine (T4) across the spectrum of thyroid states from hypothyroid (HYPO) to euthyroid to T4-induced hyperthyroid." | 7.69 | An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy. ( Dratman, MB; Gordon, JT; Greenberg, J; Tomlinson, EE, 1994) |
"To evaluate the efficacy and safety of ipodate in the treatment of hyperthyroidism in cats." | 7.69 | Ipodate treatment of hyperthyroidism in cats. ( Murray, LA; Peterson, ME, 1997) |
"We describe the effect of administration of repeated doses of sodium ipodate in a newborn infant with hyperthyroidism due to transient Graves' disease." | 7.67 | Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. ( Filetti, S; Fisher, DA; Karpman, BA; Rapoport, B, 1987) |
"A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients." | 7.66 | Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978) |
"Consecutive patients with hyperthyroidism caused by Graves' disease or by multinodular toxic goiter were randomized to be treated with high-dose propylthiouracil (PTU) to block D1, PTU plus KI, or PTU plus sodium ipodate to additionally block D2." | 5.12 | Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. ( Christensen, SE; Helleberg, K; Laurberg, P; Nielsen, S; Pedersen, KM; Seefeldt, T; Vestergaard, H, 2007) |
"Five hyperthyroid patients (two men and three women) with typical features of subacute thyroiditis were treated with sodium ipodate (Oragrafin; 0." | 5.08 | Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. ( Chopra, IJ; Korenman, SG; van Herle, AJ; Viosca, S; Younai, S, 1995) |
"05) decrease in brain uptake of both labeled T3 (T3) and labeled thyroxine (T4) across the spectrum of thyroid states from hypothyroid (HYPO) to euthyroid to T4-induced hyperthyroid." | 3.69 | An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy. ( Dratman, MB; Gordon, JT; Greenberg, J; Tomlinson, EE, 1994) |
"Two neonates with clinical manifestations and biological findings of hyperthyroidism were given calcium ipodate orally, 400 mg every 3 days, from day 26 to 50 for the first patient and from day 9 to 18 for the second in association with a beta blocker." | 3.69 | [Treatment of neonatal hyperthyroidism with calcium iopodate]. ( Bertrand, AM; Bortoluzzi, MN; Maillotte, AM; Mariani, R; Peyrade, C, 1996) |
"To evaluate the efficacy and safety of ipodate in the treatment of hyperthyroidism in cats." | 3.69 | Ipodate treatment of hyperthyroidism in cats. ( Murray, LA; Peterson, ME, 1997) |
"We describe the effect of administration of repeated doses of sodium ipodate in a newborn infant with hyperthyroidism due to transient Graves' disease." | 3.67 | Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. ( Filetti, S; Fisher, DA; Karpman, BA; Rapoport, B, 1987) |
"A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients." | 3.66 | Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978) |
"Hyperthyroidism was controlled and symptoms improved markedly in each case without any evidence of subsequent relapse of thyroiditis after withdrawal of OCAs." | 2.71 | Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis. ( Chopra, IJ; Martinez, DS, 2003) |
" Rat liver and kidney microsomes produced dose-response curves that were essentially parallel to that of LAP-744." | 1.28 | A radioimmunoassay of rat type I iodothyronine 5'-monodeiodinase. ( Chopra, IJ; Santini, F, 1992) |
" Its advantages over conventional therapy are a rapid fall in thyroid hormones and control of symptoms with a simple dosage regime." | 1.28 | Resistant hyperthyroidism induced by sodium iopodate used as treatment for Graves' disease. ( Caldwell, G; Errington, M; Toft, AD, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (40.00) | 18.7374 |
1990's | 7 (46.67) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martinez, DS | 1 |
Chopra, IJ | 6 |
Laurberg, P | 1 |
Vestergaard, H | 1 |
Nielsen, S | 1 |
Christensen, SE | 1 |
Seefeldt, T | 1 |
Helleberg, K | 1 |
Pedersen, KM | 1 |
van Herle, AJ | 1 |
Korenman, SG | 1 |
Viosca, S | 1 |
Younai, S | 1 |
Gordon, JT | 1 |
Tomlinson, EE | 1 |
Greenberg, J | 1 |
Dratman, MB | 1 |
Mariani, R | 1 |
Bertrand, AM | 1 |
Maillotte, AM | 1 |
Peyrade, C | 1 |
Bortoluzzi, MN | 1 |
Murray, LA | 1 |
Peterson, ME | 1 |
Wu, SY | 2 |
Solomon, DH | 2 |
Bennett, LR | 1 |
Santini, F | 1 |
Shen, DC | 1 |
Shian, LR | 1 |
Florsheim, W | 1 |
Pérez, JA | 1 |
Silva, R | 1 |
Norambuena, L | 1 |
López, B | 1 |
Valencia, V | 1 |
Kinast, C | 1 |
Iribarren, O | 1 |
Unger, J | 1 |
Caldwell, G | 1 |
Errington, M | 1 |
Toft, AD | 1 |
Karpman, BA | 1 |
Rapoport, B | 1 |
Filetti, S | 1 |
Fisher, DA | 1 |
Hayashi, K | 1 |
4 trials available for ipodate and Hyperthyroid
Article | Year |
---|---|
Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cholecystography; Contrast Media; Female; Humans; | 2003 |
Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.
Topics: Adolescent; Adult; Antithyroid Agents; Child; Drug Therapy, Combination; Female; Goiter, Nodular; Gr | 2007 |
Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis.
Topics: Adult; Autoantibodies; Body Weight; Female; Follow-Up Studies; Humans; Hyperthyroidism; Ipodate; Mal | 1995 |
Further studies on the long-term treatment of Graves' hyperthyroidism with ipodate: assessment of a minimal effective dose.
Topics: Adult; Dose-Response Relationship, Drug; Female; Graves Disease; Humans; Hyperthyroidism; Ipodate; M | 1991 |
11 other studies available for ipodate and Hyperthyroid
Article | Year |
---|---|
A radioimmunoassay for measurement of 3'-monoiodothyronine.
Topics: Adolescent; Adult; Amniotic Fluid; Dexamethasone; Fasting; Female; Fetal Blood; Humans; Hyperthyroid | 1980 |
An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Brain; Desipramine; Dose-Response R | 1994 |
[Treatment of neonatal hyperthyroidism with calcium iopodate].
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Female; Humans; Hyperthyroidism; Infant, New | 1996 |
Ipodate treatment of hyperthyroidism in cats.
Topics: Animals; Cat Diseases; Cats; Contrast Media; Female; Heart Rate; Hyperthyroidism; Ipodate; Male; Pro | 1997 |
Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography.
Topics: Graves Disease; Humans; Hyperthyroidism; Ipodate; Kinetics; Male; Reference Values; Thyroiditis, Aut | 1978 |
A radioimmunoassay of rat type I iodothyronine 5'-monodeiodinase.
Topics: Amino Acid Sequence; Animals; Fasting; Female; Hyperthyroidism; Hypothyroidism; Iodide Peroxidase; I | 1992 |
[Shortened preoperative preparation in diffuse hyperthyroid goiter: experience in 34 patients].
Topics: Adolescent; Adult; Dexamethasone; Drug Therapy, Combination; Female; Goiter; Humans; Hyperthyroidism | 1991 |
[Treatment of hyperthyroidism: inhibitors of T4-T3 conversion].
Topics: Adrenal Cortex Hormones; Amiodarone; Antithyroid Agents; Humans; Hyperthyroidism; Ipodate; Lithium; | 1986 |
Resistant hyperthyroidism induced by sodium iopodate used as treatment for Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Ipodate; Time Factors | 1989 |
Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate.
Topics: Antibodies; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Ipodate; Thyroid Gland | 1987 |
[Effect of various iodine-containing compounds on thyroid function tests. 2. Protein-bound iodine].
Topics: Adult; Cholecystography; Contrast Media; Diatrizoate; Female; Humans; Hyperthyroidism; Hysterosalpin | 1972 |